| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J J Morrissey, S Ishidoya, R McCracken, S Klah. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney international. Supplement. vol 54. 1996-10-25. PMID:8731201. |
the effect of ace inhibitors on the expression of matrix genes and the role of p53 and p21 (waf1) in experimental renal fibrosis. |
1996-10-25 |
2023-08-12 |
rat |
| K Masutomo, N Makino, T Maruyama, T Shimada, T Yanag. Effects of enalapril on the collagen matrix in cardiomyopathic Syrian hamsters (Bio 14.6 and 53.58). Japanese circulation journal. vol 60. issue 1. 1996-07-19. PMID:8648884. |
we attempted to determine whether an angiotensin converting enzyme (ace) inhibitor, enalapril, prevents the increase in extracellular collagen matrix which connects the myocytes in cardiomyopathy. |
1996-07-19 |
2023-08-12 |
Not clear |
| M Ruiz-Ortega, S González, D Serón, E Condom, C Bustos, R Largo, E González, A Ortiz, J Egid. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney international. vol 48. issue 6. 1996-03-27. PMID:8587237. |
ace inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. |
1996-03-27 |
2023-08-12 |
rat |
| M Ruíz-Ortega, D Gómez-Garre, R Alcázar, I Palacios, C Bustos, S González, J J Plaza, E González, J Egid. Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. vol 12. issue 4. 1994-12-29. PMID:7965275. |
to review the evidence that links angiotensin ii and endothelin as growth factors and as modifiers of extracellular matrix synthesis in renal cells, with particular reference to the effects of angiotensin converting enzyme (ace) inhibition in models of renal injury. |
1994-12-29 |
2023-08-12 |
Not clear |
| S Kim, K Yammamot. [Pharmacology of the renin-angiotensin system]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. vol 104. issue 4. 1994-12-28. PMID:7959418. |
these effects of ace inhibitors and angiotensin ii-receptor antagonists may be mediated by growth factors and the extracellular matrix. |
1994-12-28 |
2023-08-12 |
Not clear |
| D Hoelscher, G Bakri. Antihypertensive therapy and progression of diabetic renal disease. Journal of cardiovascular pharmacology. vol 23 Suppl 1. 1994-09-06. PMID:7519695. |
studies in animal models of diabetes demonstrate that the angiotensin-converting enzyme (ace) inhibitors reduce both intraglomerular volume and pressure, mesangial matrix expansion, and albuminuria. |
1994-09-06 |
2023-08-12 |
Not clear |
| J D San Antonio, J Slover, J Lawler, M J Karnovsky, A D Lande. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin. Biochemistry. vol 32. issue 18. 1993-06-11. PMID:8490019. |
to investigate specificity in the binding between extracellular matrix proteins and heparin, the method of affinity coelectrophoresis (ace) was used [lee, m. k., & lander, a. d. (1991) proc. |
1993-06-11 |
2023-08-12 |
Not clear |